With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy – Xconomy
Xconomy |
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer's Gene Therapy
Xconomy At a time when uncertainty again swirls around the development of Alzheimer's disease drugs, research continues in new ways. Through an alliance this morning, Voyager Therapeutics will team with AbbVie to try to use gene therapy tools to help attack … AbbVie steers past the wreckage, reserves $224M to kick off once-and-done gene therapy with Voyager to fight … AbbVie and Voyager Therapeutics Announce Global Strategic Collaboration to Develop Potential New Treatments for … AbbVie doubles down on tau with Voyager Alzheimer's deal |
